North America Antiviral Drugs Market Size to Hit USD 24 Billion by 2027

In terms of revenue, North America antiviral drugs market is forecast to surpass USD 24 billion by 2027.Unprecedented rise in COVID-19 cases in the U.S. and Canada has triggered the development of anti-viral therapies, stimulating North America antiviral drugs market value. With the COVID-19 infection tally exceeding 30 million and 900,000 in the U.S. and Canada, respectively, both governments and NGOs had upped investments for the discovery of the COVID-19 anti-viral candidate.

Increasing cases of viral infections diseases, such as HIV and hepatitis will bode well for the industry outlook. According to the U.S. Department of Health & Human Services, around 2.4 million people were infected with hepatitis C in the U.S. Accordingly, robust demand for active anti-viral drug therapies will propel the industry size expansion.
 
Get sample copy of this research report @ https://www.graphicalresearch.com/request/1733/sample
 
Protease inhibitors are likely to be sought-after to dent the activity of protease enzymes in the growth of human immunodeficiency virus. The innate ability of protease inhibitors to negate virus replication will bolster the product adoption. The North America antiviral drugs market revenue from the protease inhibitors segment was pegged at more than USD 4 billion in 2020 and will grow at a considerable rate in the next few years.
 
Considering the upsurge in HIV population in the U.S., growth of antiviral drugs for HIV AIDS indication will gain prominence across the region. According to a study, around 1.2 million people were infected with HIV in the U.S., with approximately 37,968 people accessing diagnosis and testing services in 2018. The HIV AIDS segment logged more than 48% market share in 2020 and is poised to surge by 2027.

 
The trend for generic antiviral drugs will be pronounced with the availability of a slew of generic drugs. Considering the cost-efficiency attribute of the antiviral drugs boosting therapeutics’ accessibility, end-users will continue to exhibit traction for the product. The industry size from the generic antiviral drugs segment exceeded USD 6.5 billion in 2020.
 
With increased risk of sexually transmitted diseases among adults, healthcare outlay will be noticeable emphasizing the adult age-group. North America antiviral drugs market revenue from the adult segment logged more than USD 8 billion in 2020 and will gain a substantial ground by 2027.
 
Canada is likely to be one of the most lucrative markets for the manufacturing of anti-viral drugs. A dramatic rise in product rollouts and R&D activities will augment the product demand. Canada antiviral drugs market revenue registered more than USD 1.5 billion in 2020.
 
North America antiviral drugs market participants will potentially focus on expanding the foothold in the U.S. as infectious diseases rise unabated. The CDC claims that around 35.5 million people were plagued with influenza, triggering close to half a million hospitalizations and claimed more than 30,000 lives during the 2018-2019 influenza season. The U.S. antiviral drugs market size is expected to surpass USD 21.5 billion by 2027.
 
Prominent companies are emphasizing partnerships, collaboration and product launches to gain a hold in the region. For instance, Cyclica collaborated with China’s Institute of Materia Medica in March 2020 to discover antiviral drug candidates for COVID-19.
 
 
Key developers in North America antiviral drugs market are Bristol-Myers Squibb, Gilead Sciences, Abbvie Inc., and Merck & Co., among others.
 
Table of Contents (ToC) of the report:

Chapter 1   Methodology
1.1    Definition and forecast parameters
1.1.1    Definitions
1.1.2    Methodology and forecast parameters
1.2    Data sources
1.3    References & sources
1.3.1    Secondary
1.3.2    Primary

Chapter 2   Executive Summary
2.1    North America anti-viral drugs market summary, 2016 – 2027
2.1.1    Country trends
2.1.2    Drug class trends
2.1.3    Indication trends
2.1.4    Type trends
2.1.5    Age-group trends

Chapter 3   Industry Insights
3.1    Industry segmentation
3.2    Industry outlook, 2016 - 2027
3.3    Major factor analysis
3.3.1    Drivers
3.3.1.1    Increasing prevalence of viral infections including COVID-19
3.3.1.2    Presence of pipeline products for HIV treatment
3.3.1.3    Increasing geriatric population
3.3.1.4    Presence of leading market players in the U
3.3.2    Industry pitfalls & challenges
3.3.2.1    Presence of generics
3.3.2.2    Rising awareness about preventive drugs treatment
3.3.2.3    Drug resistance
3.4    Analysis of COVID-19 impact on the industry
3.5    Porter’s analysis
3.6    Competitive review, 2020
3.7    PEST analysis
Browse complete Table of Contents (ToC) of this research report @ https://www.graphicalresearch.com/table-of-content/1733/north-america-anti-viral-drugs-market
 
About Graphical Research:

Graphical Research is a business research firm that provides industry insights, market forecast and strategic inputs through granular research reports and advisory services. We publish targeted research reports with an aim to address varied customer needs, from market penetration and entry strategies to portfolio management and strategic outlook. We understand that business requirements are unique: our syndicate reports are designed to ensure relevance for industry participants across the value chain. We also provide custom reports that are tailored to the exact needs of the customer, with dedicated analyst support across the purchase lifecycle.

Contact Us:
Parikhit B.
Corporate Sales,
Graphical Research
Phone: 1-800-986-6917

Comments

Post a Comment

Popular posts from this blog

3D Scanning Market Share, Trends, Segmentation and Registering a Strong Growth by End of 2027

Image
The 3D scanning market is projected to foresee commendable growth in coming years owing to high product usage across various application avenues such as aerospace & defense, entertainment & media, healthcare, and architecture & engineering among many others. 3D scanning refers to the process of collecting data from the physical object's surface which precisely describes the shape in terms of 3-dimensional space. 3D-based laser scanners are known to measure fine details as well as capture free-form shapes to rapidly generate precise point clouds. Just as 2D-based images are made up of pixels, 3D scans are made up of very tiny polygons or triangles. Get sample copy of this research report @ https://www.gminsights.com/request-sample/detail/105 The market for 3D scanning is bifurcated into different segments in terms of product, range, component, application, and regional landscape. With respect to range, the market is classified into long range, medium range, and short ...
Read more

Network Packet Broker Market to Observe Rugged Expansion at a Top CAGR by 2028 End

Image
The network packet broker market is set to exhibit robust growth through 2028 on account of prevalent product adoption in key regions across the globe. A network packet broker refers to a technology that includes a range of monitoring tools, also known as network packets, for accessing and analyzing traffic across a network. The packet broker gathers traffic from multiple network links and filters and distributes every individual packet to the proper network monitoring tool. Through this, these brokers ensure enhanced efficacy from network monitoring & security tools by providing better data from the network. Get sample copy of this research report @ https://www.gminsights.com/request-sample/detail/2930 With growing cybersecurity demands, companies are aiming to incorporate virtual traffic, and higher traffic speeds as well as greater complexity of networks have prompted them to identify effective solutions to optimize performance. The integration of network packet brokers to col...
Read more

5G Infrastructure Market Expansion Projected to Gain an Uptick During 2022-2028

Image
The 5G infrastructure market is foreseen to grow enormously through 2028 driven by exponential demand for greater bandwidth and speed capabilities. In addition, increasing government support to promote 5G deployment is primed to further fuel market growth over the forecast timeline. 5G networks provide higher speed bandwidth than existing LTE networks. During the COVID-19 outbreak, the industry witnessed a halt due to safety protocols and lockdowns. However, easing lockdown restrictions have boosted the adoption of wireless technologies, which has enhanced the focus on commercialization of the 5G infrastructure. Get sample copy of this research report @ https://www.gminsights.com/request-sample/detail/5258 Furthermore, governments are actively regulating easy market access to equipment for delivering telecom services at reasonable prices to customers. For instance, in May 2022, the Telecommunication Engineering Center (TEC), a technical division of the Department of Telecommunication...
Read more